Toward a mechanism-based in vitro safety test for pertussis toxin

References

• Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18:326 - 82; http://dx.doi.org/10.1128/CMR.18.2.326-382.2005; PMID: 15831828
   PubMed Web of Science ®Google Scholar
• Tamura M, Nogimori K, Murai S, Yajima M, Ito K, Katada T, Ui M, Ishii S. Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. Biochemistry 1982; 21:5516 - 22; http://dx.doi.org/10.1021/bi00265a021; PMID: 6293544
   PubMed Web of Science ®Google Scholar
• Guidelines for the production and control of the acellular pertussis component of monovalent of combined vaccines. WHO Technical Reports Series, WHO 1998; 878:57 - 72
   Google Scholar
• Pertussis vaccine (acellular, component, adsorbed). Eur.Pharmacopeia 2005:686-690.
   Google Scholar
• Pertussis vaccine. US Code of Federal Regulations, DC, USA, Government Printing Office 1983;58-61.
   Google Scholar
• Parfentjev IA, Goodline MA. Histamine shock in mice sensitized with Hemophilus pertussis vaccine. J Pharmacol Exp Ther 1948; 92:411 - 3; PMID: 18911838
   PubMed Web of Science ®Google Scholar
• Ishida S, Kurokawa M, Asakawa S, Iwasa S. A sensitive assay method for the histamine-sensitizing factor using change in rectal temperature of mice after histamine challenge as a response. J Biol Stand 1979; 7:21 - 9; http://dx.doi.org/10.1016/S0092-1157(79)80034-7; PMID: 489619
   PubMedGoogle Scholar
• Ochiai M, Yamamoto A, Kataoka M, Toyoizumi H, Arakawa Y, Horiuchi Y. Highly sensitive histamine-sensitization test for residual activity of pertussis toxin in acellular pertussis vaccine. Biologicals 2007; 35:259 - 64; http://dx.doi.org/10.1016/j.biologicals.2007.01.004; PMID: 17363269
   PubMed Web of Science ®Google Scholar
• Corbel MJ, Xing DK. Toxicity and potency evaluation of pertussis vaccines. Expert Rev Vaccines 2004; 3:89 - 101; http://dx.doi.org/10.1586/14760584.3.1.89; PMID: 14761246
   PubMedGoogle Scholar
• van Straaten-van de Kappelle I, van der Gun JW, Marsman FR, Hendriksen CF, van de Donk HJ. Collaborative study on test systems to assess toxicity of whole cell pertussis vaccine. Biologicals 1997; 25:41 - 57; http://dx.doi.org/10.1006/biol.1996.0059; PMID: 9167008
   PubMed Web of Science ®Google Scholar
• Yuen CT, Canthaboo C, Menzies JA, Cyr T, Whitehouse LW, Jones C, Corbel MJ, Xing D. Detection of residual pertussis toxin in vaccines using a modified ribosylation assay. Vaccine 2002; 21:44 - 52; http://dx.doi.org/10.1016/S0264-410X(02)00446-2; PMID: 12443661
   PubMed Web of Science ®Google Scholar
• Hewlett EL, Sauer KT, Myers GA, Cowell JL, Guerrant RL. Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infect Immun 1983; 40:1198 - 203; PMID: 6682833
   PubMed Web of Science ®Google Scholar
• Hoonakker ME, Ruiterkamp N, Hendriksen CF. The cAMP assay: a functional in vitro alternative to the in vivo Histamine Sensitization test. Vaccine 2010; 28:1347 - 52; http://dx.doi.org/10.1016/j.vaccine.2009.11.009; PMID: 19941995
   PubMed Web of Science ®Google Scholar
• Gillenius P, Jäätmaa E, Askelöf P, Granström M, Tiru M. The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells. J Biol Stand 1985; 13:61 - 6; http://dx.doi.org/10.1016/S0092-1157(85)80034-2; PMID: 4039324
   PubMedGoogle Scholar
• Fentem J, Chamberlain M, Sangster B. The feasibility of replacing animal testing for assessing consumer safety: a suggested future direction. Altern Lab Anim 2004; 32:617 - 23; PMID: 15757499
   PubMed Web of Science ®Google Scholar
• Toyota T, Kai Y, Kakizaki M, Sakai A, Goto Y, Yajima M, Ui M. Effects of islet-activating protein (IAP) on blood glucose and plasma insulin in healthy volunteers (phase 1 studies). Tohoku J Exp Med 1980; 130:105 - 16; http://dx.doi.org/10.1620/tjem.130.105; PMID: 6247781
   PubMed Web of Science ®Google Scholar
• Parfentjev IA, Schleyer WL. The influence of histamine on the blood sugar level of normal and sensitized mice. Arch Biochem 1949; 20:341 - 6; PMID: 18108928
   PubMed Web of Science ®Google Scholar
• Congeni BL, Orenstein DM, Nankervis GA. Three infants with neonatal pertussis: because of its atypical presentations, pertussis in the neonate may easily be overlooked. Clin Pediatr (Phila) 1978; 17:113 - 8; http://dx.doi.org/10.1177/000992287801700203; PMID: 305326
   PubMed Web of Science ®Google Scholar
• Christie CD, Baltimore RS. Pertussis in neonates. Am J Dis Child 1989; 143:1199 - 202; PMID: 2801662
   PubMedGoogle Scholar
• Verschueren H, Dewit J, Van der Wegen A, De Braekeleer J, Van Heule G, Dekegel D, De Baetselier P. The lymphocytosis promoting action of pertussis toxin can be mimicked in vitro. Holotoxin but not the B subunit inhibits invasion of human T lymphoma cells through fibroblast monolayers. J Immunol Methods 1991; 144:231 - 40; http://dx.doi.org/10.1016/0022-1759(91)90090-3; PMID: 1960420
   PubMed Web of Science ®Google Scholar
• Andreasen C, Carbonetti NH. Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice. Infect Immun 2008; 76:5139 - 48; http://dx.doi.org/10.1128/IAI.00895-08; PMID: 18765723
   PubMed Web of Science ®Google Scholar
• Schenkel AR, Pauza CD. Pertussis toxin treatment in vivo reduces surface expression of the adhesion integrin leukocyte function antigen-1 (LFA-1). Cell Adhes Commun 1999; 7:183 - 93; http://dx.doi.org/10.3109/15419069909010801; PMID: 10626903
   PubMed Web of Science ®Google Scholar
• Munoz JJ, Arai H, Bergman RK, Sadowski PL. Biological activities of crystalline pertussigen from Bordetella pertussis. Infect Immun 1981; 33:820 - 6; PMID: 6269999
   PubMed Web of Science ®Google Scholar
• Morse SI, Morse JH. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis. J Exp Med 1976; 143:1483 - 502; http://dx.doi.org/10.1084/jem.143.6.1483; PMID: 58054
   PubMed Web of Science ®Google Scholar
• Andreasen C, Powell DA, Carbonetti NH. Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice. PLoS One 2009; 4:e7079; http://dx.doi.org/10.1371/journal.pone.0007079; PMID: 19759900
   PubMed Web of Science ®Google Scholar
• Paddock CD, Sanden GN, Cherry JD, Gal AA, Langston C, Tatti KM, Wu KH, Goldsmith CS, Greer PW, Montague JL, et al. Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis 2008; 47:328 - 38; http://dx.doi.org/10.1086/589753; PMID: 18558873
   PubMed Web of Science ®Google Scholar
• Menkes JH, Kinsbourne M. Workshop on neurologic complications of pertussis and pertussis vaccination. Neuropediatrics 1990; 21:171 - 6; http://dx.doi.org/10.1055/s-2008-1071488; PMID: 1981251
   PubMed Web of Science ®Google Scholar
• Grant CC, McKay EJ, Simpson A, Buckley D. Pertussis encephalopathy with high cerebrospinal fluid antibody titers to pertussis toxin and filamentous hemagglutinin. Pediatrics 1998; 102:986 - 90; http://dx.doi.org/10.1542/peds.102.4.986; PMID: 9755273
   PubMed Web of Science ®Google Scholar
• Kügler S, Böcker K, Heusipp G, Greune L, Kim KS, Schmidt MA. Pertussis toxin transiently affects barrier integrity, organelle organization and transmigration of monocytes in a human brain microvascular endothelial cell barrier model. Cell Microbiol 2007; 9:619 - 32; http://dx.doi.org/10.1111/j.1462-5822.2006.00813.x; PMID: 17002784
   PubMed Web of Science ®Google Scholar
• Kerfoot SM, Long EM, Hickey MJ, Andonegui G, Lapointe BM, Zanardo RC, Bonder C, James WG, Robbins SM, Kubes P. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J Immunol 2004; 173:7070 - 7; PMID: 15557205
   PubMed Web of Science ®Google Scholar
• Brückener KE, el Bayâ A, Galla HJ, Schmidt MA. Permeabilization in a cerebral endothelial barrier model by pertussis toxin involves the PKC effector pathway and is abolished by elevated levels of cAMP. J Cell Sci 2003; 116:1837 - 46; http://dx.doi.org/10.1242/jcs.00378; PMID: 12665564
   PubMed Web of Science ®Google Scholar
• Locht C, Keith JM. Pertussis toxin gene: nucleotide sequence and genetic organization. Science 1986; 232:1258 - 64; http://dx.doi.org/10.1126/science.3704651; PMID: 3704651
   PubMed Web of Science ®Google Scholar
• Tamura M, Nogimori K, Yajima M, Ase K, Ui M. A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells. J Biol Chem 1983; 258:6756 - 61; PMID: 6343381
   PubMed Web of Science ®Google Scholar
• Katada T, Ui M. Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. Proc Natl Acad Sci U S A 1982; 79:3129 - 33; http://dx.doi.org/10.1073/pnas.79.10.3129; PMID: 6954463
   PubMed Web of Science ®Google Scholar
• Gierschik P. ADP-ribosylation of signal-transducing guanine nucleotide-binding proteins by pertussis toxin. Curr Top Microbiol Immunol 1992; 175:69 - 96; http://dx.doi.org/10.1007/978-3-642-76966-5_4; PMID: 1628499
   PubMed Web of Science ®Google Scholar
• Murayama T, Ui M. Loss of the inhibitory function of the guanine nucleotide regulatory component of adenylate cyclase due to its ADP ribosylation by islet-activating protein, pertussis toxin, in adipocyte membranes. J Biol Chem 1983; 258:3319 - 26; PMID: 6298231
   PubMed Web of Science ®Google Scholar
• Bokoch GM, Gilman AG. Inhibition of receptor-mediated release of arachidonic acid by pertussis toxin. Cell 1984; 39:301 - 8; http://dx.doi.org/10.1016/0092-8674(84)90008-4; PMID: 6094010
   PubMed Web of Science ®Google Scholar
• Katada T, Ui M. Islet-activating protein. A modifier of receptor-mediated regulation of rat islet adenylate cyclase. J Biol Chem 1981; 256:8310 - 7; PMID: 7021547
   PubMed Web of Science ®Google Scholar
• Yajima M, Hosoda K, Kanbayashi Y, Nakamura T, Nogimori K, Mizushima Y, Nakase Y, Ui M. Islets-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory responses of rats. Purification and characterization. J Biochem 1978; 83:295 - 303; PMID: 203574
   PubMed Web of Science ®Google Scholar
• Regard JB, Kataoka H, Cano DA, Camerer E, Yin L, Zheng YW, Scanlan TS, Hebrok M, Coughlin SR. Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J Clin Invest 2007; 117:4034 - 43; PMID: 17992256
   PubMed Web of Science ®Google Scholar
• van Meijeren CE, Vleeming W, van de Kuil T, Gerards AL, Hendriksen CF, de Wildt DJ. Pertussis toxin-induced histamine sensitisation: an aspecific phenomenon independent from the nitric oxide system?. Eur J Pharmacol 2004; 493:139 - 50; http://dx.doi.org/10.1016/j.ejphar.2004.04.014; PMID: 15189775
   PubMed Web of Science ®Google Scholar
• Petitcolin MA, Spitzbarth-Régrigny E, Bueb JL, Capdeville-Atkinson C, Tschirhart E. Role of G(i)-proteins in norepinephrine-mediated vasoconstriction in rat tail artery smooth muscle. Biochem Pharmacol 2001; 61:1169 - 75; http://dx.doi.org/10.1016/S0006-2952(01)00589-5; PMID: 11301051
   PubMed Web of Science ®Google Scholar
• Gurdal H, Seasholtz TM, Wang HY, Brown RD, Johnson MD, Friedman E. Role of G alpha q or G alpha o proteins in alpha 1-adrenoceptor subtype-mediated responses in Fischer 344 rat aorta. Mol Pharmacol 1997; 52:1064 - 70; PMID: 9415716
   PubMed Web of Science ®Google Scholar
• Clerch LB, Neithardt G, Spencer U, Melendez JA, Massaro GD, Massaro D. Pertussis toxin treatment alters manganese superoxide dismutase activity in lung. Evidence for lung oxygen toxicity in air-breathing rats. J Clin Invest 1994; 93:2482 - 9; http://dx.doi.org/10.1172/JCI117257; PMID: 8200984
   PubMed Web of Science ®Google Scholar
• Tsan MF, Cao X, White JE, Sacco J, Lee CY. Pertussis toxin-induced lung edema. Role of manganese superoxide dismutase and protein kinase C. Am J Respir Cell Mol Biol 1999; 20:465 - 73; http://dx.doi.org/10.1165/ajrcmb.20.3.3373; PMID: 10030845
   PubMed Web of Science ®Google Scholar
• Garcia JG, Wang P, Schaphorst KL, Becker PM, Borbiev T, Liu F, Birukova A, Jacobs K, Bogatcheva N, Verin AD. Critical involvement of p38 MAP kinase in pertussis toxin-induced cytoskeletal reorganization and lung permeability. FASEB J 2002; 16:1064 - 76; http://dx.doi.org/10.1096/fj.01-0895com; PMID: 12087068
   PubMed Web of Science ®Google Scholar
• Agarwal RK, Sun SH, Su SB, Chan CC, Caspi RR. Pertussis toxin alters the innate and the adaptive immune responses in a pertussis-dependent model of autoimmunity. J Neuroimmunol 2002; 129:133 - 40; http://dx.doi.org/10.1016/S0165-5728(02)00203-5; PMID: 12161029
   PubMed Web of Science ®Google Scholar
• Carbonetti NH, Artamonova GV, Van Rooijen N, Ayala VI. Pertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tract. Infect Immun 2007; 75:1713 - 20; http://dx.doi.org/10.1128/IAI.01578-06; PMID: 17242062
   PubMed Web of Science ®Google Scholar
• Kirimanjeswara GS, Agosto LM, Kennett MJ, Bjornstad ON, Harvill ET. Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest 2005; 115:3594 - 601; http://dx.doi.org/10.1172/JCI24609; PMID: 16294220
   PubMed Web of Science ®Google Scholar
• Yajima M, Hosoda K, Kanbayashi Y, Nakamura T, Takahashi I, Ui M. Biological properties of islets-activating protein (IAP) purified from the culture medium of Bordetella pertussis. J Biochem 1978; 83:305 - 12; PMID: 203575
   PubMed Web of Science ®Google Scholar
• Rosoff PM, Walker R, Winberry L. Pertussis toxin triggers rapid second messenger production in human T lymphocytes. J Immunol 1987; 139:2419 - 23; PMID: 2958548
   PubMed Web of Science ®Google Scholar
• Li H, Wong WS. Pertussis toxin activates tyrosine kinase signaling cascade in myelomonocytic cells: a mechanism for cell adhesion. Biochem Biophys Res Commun 2001; 283:1077 - 82; http://dx.doi.org/10.1006/bbrc.2001.4910; PMID: 11355882
   PubMed Web of Science ®Google Scholar
• Loosmore S, Zealey G, Cockle S, Boux H, Chong P, Yacoob R, Klein M. Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits. Infect Immun 1993; 61:2316 - 24; PMID: 8500874
   PubMed Web of Science ®Google Scholar
• Lei MG, Morrison DC. Evidence that lipopolysaccharide and pertussis toxin bind to different domains on the same p73 receptor on murine splenocytes. Infect Immun 1993; 61:1359 - 64; PMID: 7681044
   PubMed Web of Science ®Google Scholar
• Wong WS, Luk JM. Signaling mechanisms of pertussis toxin-induced myelomonocytic cell adhesion: role of tyrosine phosphorylation. Biochem Biophys Res Commun 1997; 236:479 - 82; http://dx.doi.org/10.1006/bbrc.1997.6986; PMID: 9240464
   PubMed Web of Science ®Google Scholar
• Wong WS, Simon DI, Rosoff PM, Rao NK, Chapman HA. Mechanisms of pertussis toxin-induced myelomonocytic cell adhesion: role of Mac-1(CD11b/CD18) and urokinase receptor (CD87). Immunology 1996; 88:90 - 7; http://dx.doi.org/10.1046/j.1365-2567.1996.d01-646.x; PMID: 8707356
   PubMed Web of Science ®Google Scholar
• Rogers TS, Corey SJ, Rosoff PM. Identification of a 43-kilodalton human T lymphocyte membrane protein as a receptor for pertussis toxin. J Immunol 1990; 145:678 - 83; PMID: 2164067
   PubMed Web of Science ®Google Scholar
• Gray LS, Huber KS, Gray MC, Hewlett EL, Engelhard VH. Pertussis toxin effects on T lymphocytes are mediated through CD3 and not by pertussis toxin catalyzed modification of a G protein. J Immunol 1989; 142:1631 - 8; PMID: 2521885
   PubMed Web of Science ®Google Scholar
• Schneider OD, Weiss AA, Miller WE. Pertussis toxin signals through the TCR to initiate cross-desensitization of the chemokine receptor CXCR4. J Immunol 2009; 182:5730 - 9; http://dx.doi.org/10.4049/jimmunol.0803114; PMID: 19380820
   PubMed Web of Science ®Google Scholar
• Schneider OD, Weiss AA, Miller WE. Pertussis toxin utilizes proximal components of the T-cell receptor complex to initiate signal transduction events in T cells. Infect Immun 2007; 75:4040 - 9; http://dx.doi.org/10.1128/IAI.00414-07; PMID: 17562776
   PubMed Web of Science ®Google Scholar
• Sindt KA, Hewlett EL, Redpath GT, Rappuoli R, Gray LS, Vandenberg SR. Pertussis toxin activates platelets through an interaction with platelet glycoprotein Ib. Infect Immun 1994; 62:3108 - 14; PMID: 8039878
   PubMed Web of Science ®Google Scholar
• Wang ZY, Yang D, Chen Q, Leifer CA, Segal DM, Su SB, Caspi RR, Howard ZO, Oppenheim JJ. Induction of dendritic cell maturation by pertussis toxin and its B subunit differentially initiate Toll-like receptor 4-dependent signal transduction pathways. Exp Hematol 2006; 34:1115 - 24; http://dx.doi.org/10.1016/j.exphem.2006.04.025; PMID: 16863919
   PubMed Web of Science ®Google Scholar
• Nasso M, Fedele G, Spensieri F, Palazzo R, Costantino P, Rappuoli R, Ausiello CM. Genetically detoxified pertussis toxin induces Th1/Th17 immune response through MAPKs and IL-10-dependent mechanisms. J Immunol 2009; 183:1892 - 9; http://dx.doi.org/10.4049/jimmunol.0901071; PMID: 19596995
   PubMed Web of Science ®Google Scholar
• Nishida M, Suda R, Nagamatsu Y, Tanabe S, Onohara N, Nakaya M, Kanaho Y, Shibata T, Uchida K, Sumimoto H, et al. Pertussis toxin up-regulates angiotensin type 1 receptors through Toll-like receptor 4-mediated Rac activation. J Biol Chem 2010; 285:15268 - 77; http://dx.doi.org/10.1074/jbc.M109.076232; PMID: 20231290
   PubMed Web of Science ®Google Scholar
• Garcia JG, Wang P, Liu F, Hershenson MB, Borbiev T, Verin AD. Pertussis toxin directly activates endothelial cell p42/p44 MAP kinases via a novel signaling pathway. Am J Physiol Cell Physiol 2001; 280:C1233 - 41; PMID: 11287337
   PubMedGoogle Scholar
• Ausiello CM, Fedele G, Urbani F, Lande R, Di Carlo B, Cassone A. Native and genetically inactivated pertussis toxins induce human dendritic cell maturation and synergize with lipopolysaccharide in promoting T helper type 1 responses. J Infect Dis 2002; 186:351 - 60; http://dx.doi.org/10.1086/341510; PMID: 12134231
   PubMed Web of Science ®Google Scholar
• Tonon S, Goriely S, Aksoy E, Pradier O, Del Giudice G, Trannoy E, Willems F, Goldman M, De Wit D. Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns. Eur J Immunol 2002; 32:3118 - 25; http://dx.doi.org/10.1002/1521-4141(200211)32:11<3118::AID-IMMU3118>3.0.CO;2-B; PMID: 12385032
   PubMed Web of Science ®Google Scholar
• Vaessen SF, Verkoeijen S, Vandebriel RJ, Bruysters MW, Pennings JL, Bos R, Krul CA, Akkermans AM. Identification of biomarkers to detect residual pertussis toxin using microarray analysis of dendritic cells. Vaccine 2013; 31:5223 - 31; http://dx.doi.org/10.1016/j.vaccine.2013.08.082; PMID: 24055089
   PubMed Web of Science ®Google Scholar